✦ LIBER ✦

PND19 AT ALIZUMAB REDUCES RELAPSE-ASSOCIATED COSTS HOSPITALIZATIONS IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

✍ Scribed by K O'Day; K Meyer; K Rajagopalan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND9 THE COST-EFFECTIVENESS OF NATALIZUM

✍ K Meyer; E Chiao 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PND10 Cost of Relapse Resulting in Hospi

✍ C. Kozma; D.M. Meletiche; A.L. Phillips 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PND19 A LONG-TERM COST-EFFECTIVENESS MAR

✍ C Plesnila-Frank; N Putzki; D Eheberg; V Limmroth; Z Katsarava; SN Patel 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PND33 Cost Minimization Analysis of Fing

✍ B. Verheggen; M. Treur; M. Groot 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PND30 Cost Analysis of Glatiramer Acetat

✍ Sánchez-de la Rosa, R.; Sabater, E.; Casado, M.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Fingolimod reduces direct medical costs

✍ Heisen, M.; Treur, M. J.; van der Hel, W. S.; Frequin, S. T. F. M.; Groot, M. T. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 645 KB